Managing feline immune-mediated diseases requires balancing immunosuppression efficacy against side effects - careful monitoring maintains welfare.
Long-term immunosuppression management requires careful monitoring to maintain the welfare benefit of disease control while minimising the welfare cost of treatment side effects. The goal is the lowest effective dose that maintains quality of life.